New US clinical trial shows benefits of Pepcid for treating mild to moderate COVID-19

tbrnewsmedia.com
March 2, 2022

Clinical trial results, published in the British Medical Journal Gut, demonstrate that the anti-ulcer drug famotidine (also known as Pepcid), leads to faster COVID-19 symptom recovery in patients diagnosed with mild to moderate COVID-19.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!